Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natálya G. Pereira"'
Autor:
Ricardo Rohweder, Natálya G. Pereira, Bruna H. Micheletti, Jéssica Mosello, Júlia R. M. Campos, Matheus G. Pereira, Cristina N. Santos, Natália L. Simões, Regina L. B. Matielo, Lisandra S. Bernardes, Maria L. R. Oppermann, Maria C. O. Wender, Angela Lupattelli, Hedvig Nordeng, Lavinia Schuler-Faccini
Publikováno v:
Journal of Pregnancy, Vol 2024 (2024)
There is limited evidence about the use of medications among pregnant women with COVID-19, as well as risk factors for hospitalization due to COVID-19 in pregnancy. We aimed to describe the use of medications among SARS-CoV-2-positive pregnant women
Externí odkaz:
https://doaj.org/article/ba491e96ecaf46ce91a55e312f09eb93
Autor:
Fernanda Rolemberg G Riba, Denise P. Cavalcanti, Natana Chaves Rabelo, Maria Celia C Zuma, Natálya G. Pereira, Maria Teresa Vieira Sanseverino, Thatiane Yoshie Kanazawa, Sayonara Gonzalez, Maria E.S. Gomes, Dafne Dain Gandelman Horovitz, Juan C. Llerena
Publikováno v:
Molecular Syndromology. 9:92-99
Mutations in the fibroblast growth factor receptor 3 gene (FGFR3) cause achondroplasia (ACH), hypochondroplasia (HCH), and thanatophoric dysplasia types I and II (TDI/TDII). In this study, we performed a genetic study of 123 Brazilian patients with t
Autor:
Maria E S, Gomes, Thatiane Y, Kanazawa, Fernanda R, Riba, Natálya G, Pereira, Maria C C, Zuma, Natana C, Rabelo, Maria T, Sanseverino, Dafne D G, Horovitz, Juan C, Llerena, Denise P, Cavalcanti, Sayonara, Gonzalez
Publikováno v:
Molecular syndromology. 9(2)
Mutations in the fibroblast growth factor receptor 3 gene (FGFR3) cause achondroplasia (ACH), hypochondroplasia (HCH), and thanatophoric dysplasia types I and II (TDI/TDII). In this study, we performed a genetic study of 123 Brazilian patients with t